COMPANY

Nuago Therapeutics Inc.

Keywords: oncology cancer RNA therapeutics hepatocellular carcinoma

Location: Chicago, IL · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 2

Annual award amounts. Total $800K.

Jun 9, 2025 NIH award 1R42CA291346-01A1 FY2025: $400,000 awarded for that fiscal year; activity R42 (STTR); PI SCHICKEL, ROBERT; recipient as written: NUAGO THERAPEUTICS INC, CHICAGO, IL. Development of a DISE-inducing, short RN source ↗
Sep 19, 2024 NIH award 1R41CA287846-01A1 FY2024: $400,000 awarded for that fiscal year; activity R41 (STTR); PI SCHICKEL, ROBERT; recipient as written: NUAGO THERAPEUTICS INC, CHICAGO, IL. Development of a novel, RNA-interference source ↗